Overview Financials News + Filings
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| 10-K | 10-K | 10-K | 10-K/A | 10-K |
Revenues: |
Entities D | | | | | 0.2 |
Other | | | | | 0.4 |
Total revenues | 0.3 | 0.7 | 1.4 | 0.7 | 0.6 |
Revenue growth | -57.1% | -45.5% | 90.9% | 21.9% | |
Cost of goods sold | 0.2 | 0.8 | 1.5 | 0.6 | 0.5 |
Gross profit | 0.1 | -0.1 | -0.1 | 0.1 | 0.1 |
Gross margin | 28.8% | -11.1% | -5.7% | 18.1% | 22.5% |
Selling, general and administrative | 2.7 | 2.0 | 1.4 | 1.4 | 0.0 |
Research and development | 2.1 | 1.5 | 0.6 | 0.2 | |
Other operating expenses | 0.2 | | | | |
EBITDA [+] | -4.6 | -3.4 | -1.9 | -1.5 | 0.1 |
EBITDA growth | 36.9% | 75.9% | 32.6% | -1294.7% | |
EBITDA margin | -1446.1% | -452.8% | -140.3% | -202.0% | 20.6% |
Depreciation and amortization | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
EBIT [+] | -4.8 | -3.6 | -2.0 | -1.5 | 0.1 |
EBIT growth | 35.4% | 74.4% | 39.8% | -1333.6% | |
EBIT margin | -1500.4% | -475.0% | -148.4% | -202.7% | 20.0% |
Interest expense, net [+] | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Interest expense | 0.1 | 0.0 | 0.0 | | |
Interest income | | | | 0.0 | 0.0 |
Other income (expense), net | -0.8 | 0.4 | | | |
Pre-tax income | -5.7 | -3.1 | -2.0 | -1.5 | 0.1 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | |
Net income | -5.7 | -3.1 | -2.0 | -1.5 | 0.1 |
Net margin | -1773.4% | -419.5% | -148.7% | -202.6% | 20.2% |
|
Basic EPS [+] | ($0.36) | ($0.25) | ($0.18) | ($0.18) | $0.02 |
Growth | 43.1% | 39.0% | 3.1% | -888.2% | |
Diluted EPS [+] | ($0.36) | ($0.25) | ($0.18) | ($0.18) | $0.02 |
Growth | 43.1% | 39.0% | 3.1% | -888.2% | |
|
Dividends per share [+] | | | | | $0.00 |
Growth | | | | -100.0% | |
|
Shares outstanding (basic) [+] | 15.7 | 12.4 | 11.2 | 8.3 | 5.3 |
Growth | 26.6% | 10.6% | 35.9% | 55.4% | |
Shares outstanding (diluted) [+] | 15.7 | 12.4 | 11.2 | 8.3 | 5.3 |
Growth | 26.6% | 10.6% | 35.9% | 55.4% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|